Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
University of California, San Diego
Mayo Clinic
National Cancer Institute (NCI)
Boehringer Ingelheim
University of California, San Diego
Hoffmann-La Roche
Intensity Therapeutics, Inc.
Vaccinex Inc.
Helsinki University Central Hospital
Amgen
The University of Texas Health Science Center at San Antonio
Genocea Biosciences, Inc.
Akamis Bio
Celgene
Liverpool University Hospitals NHS Foundation Trust
University of Chicago
Eli Lilly and Company
Massachusetts General Hospital
University of Chicago
Stanford University
Sanofi
Oncolytics Biotech
Oncolytics Biotech
Merck KGaA, Darmstadt, Germany
University of Michigan Rogel Cancer Center
Memorial Sloan Kettering Cancer Center
Pfizer
AstraZeneca
Baylor College of Medicine
Vical